Benjamin F. Edwards & Company’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-183
| Closed | -$8K | – | 1826 |
|
|
2021
Q4 | $8K | Hold |
183
| – | – | ﹤0.01% | 1437 |
|
|
2021
Q3 | $8K | Hold |
183
| – | – | ﹤0.01% | 1437 |
|
|
2021
Q2 | $10K | Hold |
183
| – | – | ﹤0.01% | 1389 |
|
|
2021
Q1 | $14K | Hold |
183
| – | – | ﹤0.01% | 1287 |
|
|
2020
Q4 | $16K | Hold |
183
| – | – | ﹤0.01% | 1190 |
|
|
2020
Q3 | $11K | Hold |
183
| – | – | ﹤0.01% | 1259 |
|
|
2020
Q2 | $8K | Hold |
183
| – | – | ﹤0.01% | 1340 |
|
|
2020
Q1 | $5K | Hold |
183
| – | – | ﹤0.01% | 1441 |
|
|
2019
Q4 | $13K | Hold |
183
| – | – | ﹤0.01% | 1353 |
|
|
2019
Q3 | $26K | Buy |
183
+50
| +38% | +$7.1K | ﹤0.01% | 1114 |
|
|
2019
Q2 | $24K | Hold |
133
| – | – | ﹤0.01% | 1140 |
|
|
2019
Q1 | $21K | Sell |
133
-167
| -56% | -$26.4K | ﹤0.01% | 1123 |
|
|
2018
Q4 | $29K | Buy |
+300
| New | +$29K | ﹤0.01% | 988 |
|